Literature DB >> 11678329

Proliferative and apoptotic activity in hepatocellular carcinoma and surrounding non-neoplastic liver tissue.

J Pizem1, V F Marolt, B Luzar, A Cör.   

Abstract

UNLABELLED: The aim of the study was to determine the proliferative and apoptotic activity of neoplastic and non-neoplastic hepatocytes, to ascertain whether there was a correlation between the histopathological characteristics of hepatocellular carcinoma (HCC) and its proliferative or apoptotic activity.
METHODS: One tumour sample and one sample of non-neoplastic liver from 16 patients with HCC were analysed. The proliferative activity was established by immunohistochemical staining against PCNA (proliferating cell nuclear antigen) and Ki-67. Apoptotic activity was determined by morphological and TUNEL methods. Bcl-2 immunoreactivity was analysed.
RESULTS: A positive correlation between PCNA and Ki-67 proliferative indexes was found in HCC (p < 0.01). The PCNA index was 0.21% +/- 0.80% (Mean +/- SD) in non-neoplastic liver and 7.41% +/- 8.22% in HCC, while the Ki-67 index was 0.19% +/- 0.26% in non-neoplastic liver and 9.67% +/- 7.70% in HCC. The differences between HCC and non-neoplastic liver were significant (p < 0.05). The PCNA index differed significantly between different HCC grades (p < 0.05). In HCC and non-neoplastic liver samples, apoptotic indexes (AI) assessed morphologically were higher than Al determined by the TUNEL method. Differences in Al (irrespective of the method used) between different HCC grades were not significant. Bcl-2 staining was positive in one non-neoplastic liver sample (6.3%) and in 4 HCC samples (25%).
CONCLUSIONS: PCNA and Ki-67 were useful for proliferative activity assessment of hepatocytes. There were no differences in apoptotic activity between HCC and non-neoplastic tissue, so it seems that uncontrolled tumour cell division plays an important role in HCC growth. In the regulation of the apoptotic process in HCC, Bcl-2 could be important.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11678329     DOI: 10.1007/s004240100014

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  6 in total

1.  Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.

Authors:  Zhao Jing; Ke-Jun Nan; Mei-Long Hu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

2.  Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits hepatocellular carcinoma in vitro and in vivo via stabilizing IkBα.

Authors:  George G Chen; Jackie Leung; Nian Ci Liang; Li Li; Kefeng Wu; Ursula P F Chan; Billy C S Leung; Mingyue Li; Jing Du; Yi Feng Deng; Xianling Gong; Yingnian Lv; Ernest C W Chak; Paul B S Lai
Journal:  Invest New Drugs       Date:  2012-01-07       Impact factor: 3.850

3.  Extended liver resection after preoperative chemotherapy: influence on regeneration and endoplasmic reticulum stress response.

Authors:  Steffen Manekeller; Alexandra Seinsche; Maria Sioutis; Andreas Hirner
Journal:  Langenbecks Arch Surg       Date:  2008-08-08       Impact factor: 3.445

4.  Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma.

Authors:  Shi-Qiang Shen; Kun Li; Neng Zhu; Akimasa Nakao
Journal:  Med Oncol       Date:  2008-01-23       Impact factor: 3.064

5.  Isatin Counteracts Diethylnitrosamine/2-Acetylaminofluorene-Induced Hepatocarcinogenesis in Male Wistar Rats by Upregulating Anti-Inflammatory, Antioxidant, and Detoxification Pathways.

Authors:  Nagwa G Tawfik; Wafaa R Mohamed; Hanan S Mahmoud; Mohammed A Alqarni; Ibrahim A Naguib; Alzhraa M Fahmy; Osama M Ahmed
Journal:  Antioxidants (Basel)       Date:  2022-04-01

6.  The Apoptotic Effect of Trichinella spiralis Infection Against Experimentally Induced Hepatocellular Carcinoma.

Authors:  Fawzya A Elhasawy; Dalia S Ashour; Ayman M Elsaka; Howaida I Ismail
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.